Evaluating the Safety, Efficacy and Patient Acceptability of Intravitreal Fluocinolone Acetonide (0.2mcg/Day) Implant in the Treatment of Non-Infectious Uveitis Affecting the Posterior Segment

Evaluating the Safety, Efficacy and Patient Acceptability of Intravitreal Fluocinolone Acetonide (0.2mcg/Day) Implant in the Treatment of Non-Infectious Uveitis Affecting the Posterior Segment

Laura R Steeples,1,2 Sasa Pockar,1 Nicholas P Jones,1,2 Inês Leal3,4 1Manchester Royal Eye Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; 2Faculty of Biology, Medicine & Health, University of Manchester, Ma...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Steeples LR, Pockar S, Jones NP, Leal I
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
fluocinolone acetonide implant
non-infectious uveitis
posterior segment
efficacy
safety
Ophthalmology
RE1-994
Acceso en línea:https://doaj.org/article/67b04b7854c04221a490dc443f4e7674
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/67b04b7854c04221a490dc443f4e7674

Ejemplares similares